jardiance vs glp-1 Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study Jardiance vs Victoza: Practical Comparison

Risks vs benefits for SGLT2 inhibitor medications

Supplementation works best when the basics are not working against it

So the defensible position on BPC-157 vs TB-500 is that both show reproducible, mechanistically interesting healing and angiogenic effects in preclinical systems, but neither has demonstrated safety or efficacy in adequately powered human trials

On the average, our patients seem to get the best benefits in the first 6 9 months of treatment

This accomplishes two things: it reduces GI side effects that can be harder to tolerate when youre already managing disease-related fatigue and symptoms, and it gives you and your care team time to watch for any changes in disease activity